CEE
Meeting category
Date(s)
11 Oct 2018 - 12 Oct 2018
Location
Prague, Czechia
Organizer

Central and Eastern European Meeting on Viral Hepatitis and HIV 2018

Related Enduring Materials

Enduring Materials

Day 1 - Thursday, 11 September 2018

Session 1: Epidemiology of HIV and hepatitis in the CEE countries - 09:10
09:10 CEST
Epidemiology of HIV Infection and Treatment in Europe
Teymur Noori, MSc
European Centre for Disease Prevention and Control (ECDC), Sweden
09:35 CEST
Update on changes in Hepatitis B and C in CEE countries
Miłosz Parczewski, MD, PhD
Pomeranian Medical University, Szczecin, Poland
10:00 CEST
How can new diagnostics help to increase the number diagnosed?
Elena Ivanova Reipold, MD, PhD
Foundation for Innovative New Diagnostics (FIND), Switzerland
10:25 CEST
Country models: what has and what hasn’t worked
Nikoloz Chkhartishvili, MD, MS, PhD
Infectious Diseases, AIDS and Clinical Immunology Research Center, Georgia
Zahedul Islam
Zahedul Islam, MBA
Alliance for Public Health, Kiev, Ukraine
Session 2: Challenges in HIV and viral hepatitis - 11:40
11:40 CEST
Hepatitis Delta: what are the new developments, what are the challenges?
Cihan Yurdaydin, MD
Department of Gastroenterology and Hepatology, University Medical School, Istanbul, Turkey
12:05 CEST
HIV & women’s health: do we have any game changers here?
Mariana Mărdărescu, MD, PhD
Institute for Infectious Disease Matei Bals, Romania
Special session: Improving care of treatment-experienced patients - 13:45
13:45 CEST
Approach to managing treatment-experienced patients
Jonathan Schapiro, MD
National Hemophilia Center, Sheba Medical Center, Israel
14:00 CEST
Utilizing new diagnostics, web-tools and drugs for optimal care of treatment-experienced patients. A case-based joint presentation
Jonathan Schapiro, MD
National Hemophilia Center, Sheba Medical Center, Israel
David Back, PhD
University of Liverpool, United Kingdom
14:15 CEST
Treatment-experienced patients in Central and Eastern Europe – What needs to be done?
Viktor Aster
Viktor Aster, MD, PhD
Charles University, Prague, Czech Republic
Session 3: Switching HIV therapy: considerations and strategies - 14:45
14:45 CEST
Clinical considerations in switching antiretroviral therapy
David Jilich, MD, Ph.D
Hospital Na Bulovce, Czech Republic
15:05 CEST
Clinical Case Discussion: Switching HIV Therapy
Pavel Khaykin, MD
MainFachArzt Frankfurt, Germany
Session 4: Abstract - driven presentations - 16:05
16:05 CEST
Real-life effectiveness of ledipasvir/sofosbuvir regimen and factors associated with retention in care among HIV/HCV co-infected PWID in Ukraine
Tetyana Kyrychenko, Ukraine
#1
16:15 CEST
Possible misclassification of HIV transmission between men: results of phylogenetic analysis
Natia Dvali, Georgia
#2
16:25 CEST
Epidemiology of HIV in the Baltic countries (Estonia, Latvia, Lithuania)
Saulius Caplinskas, Lithuania
#3
16:35 CEST
Socio-demographic risk factors for high HEV seroprevalence among liver transplant recipients in Croatia
Anna Mrzljak, Croatia
#4
16:45 CEST
Spontaneous HCV clearance in HCV/HIV coinfected patients from AIDS Center Prague
Viktor Aster, Czech Republic
#5
17:00 CEST
Industry-sponsored Symposium

Day 2 - Friday, 12 October 2018

- 08:30
08:30 CEST
Industry - sponsored symposium
Session 5: Management of hepatitis C - 09:30
09:30 CEST
Critical assessment of the global epidemiology of HCV
Peter Ferenci
Peter Ferenci, MD
University of Vienna, Vienna, Austria
09:55 CEST
Liver transplantation for HCV and HBV in The Czech Republic
Soña Frankova
Soña Frankova, MD, PhD
IKEM Prague transplant center, Prague, Czech Republic
10:20 CEST
Case Study: The changing IV drug use problem/pattern and what that means to the epidemic
Mojca Matičič, MD, PhD
University of Ljubljana, Slovenia
10:45 CEST
The EpiTer-2 database
Robert Flisiak
Robert Flisiak, MD, PhD
Medical University of Bialystok, Bialystok, Poland
Session 6: Hepatitis B cure strategies: how far are we? - 11:45
11:45 CEST
Hepatitis B cure strategies: how far are we?
Heiner Wedemeyer
Heiner Wedemeyer, MD
University Clinic Essen, Essen, Germany
Abstract-driven presentations
12:10 CEST
Mortality and causes of death among HIV/HCV co-infected persons in the Eastern European country of Georgia
Akaki Abutidze, Georgia
#6
12:20 CEST
HCV resistance-associated variants among HCV treatment naïve HIVcoinfected patients in Ukraine. A pilot study
Marta Vasylyev, Ukraine
#7
Session 7: Hot topics in HIV and hepatitis - 13:30
13:30 CEST
New delivery systems and long acting antiretroviral drugs
David Back, PhD
University of Liverpool, United Kingdom
13:55 CEST
HIV PrEP
Pep Coll, MD
AIDS Research Institute-IrsiCaixa, Spain
Abstract-driven presentations
14:20 CEST
Early results of pre-exposure prophylaxis program in Georgia
Nikoloz Chkhartishvili, Georgia
#8
14:30 CEST
The Regression of Liver Fibrosis in HCV Cirrhotic Patients Who Registered SVR after DAA Therapy
Anca Leustean, Romania
#9
14:40 CEST
Approaches to providing hepatitis C viremia testing to people who inject drugs in Georgia
Maia Japaridze, Georgia
#10
14:50 CEST
Insulin-like growth factor and platelet-derived growth factor in liver cells of patients with chronic hepatitis C at different stages of fibrosis
Igor Tikhonov, Russia
#11
Overview
Welcome

Over 160 attendees from 27 different countries met on 11 and 12 October, 2018 in Prague, Czech Republic for the Fourth edition of the Central and Eastern European Meeting on Viral Hepatitis and HIV.

On behalf of the Organizing Committee, we would like to express our appreciation to our sponsors ViiV Healthcare, Gilead Sciences and AbbVie for their generous support. We would also like to thank our endorsers for their invaluable support of the meeting, and, of course, all our participants for their contribution in making this meeting so successful,

Practical Information 

Language
The official language of the meeting was English.
Disclaimer
This meeting is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this meeting, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the meeting.
Liability and Insurance
By registering for the meeting participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the meeting is finished, provided the speaker has given permission to do so.
Committees
Conference Chairs
Organizing Committee

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

Cihan Yurdaydin
Cihan Yurdaydin, MD
Department of Gastroenterology and Hepatology, University Medical School, Istanbul, Turkey
Andrzej Horban
Andrzej Horban, MD, PhD
Hospital for Infectious Diseases, Poland
Scientific Committee

The members of Scientific Committee assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

  • Marine Gogia, MD, Georgian Harm Reduction Network, Georgia
  • Brygida Knysz, MD, PhD, Medical University of Wroclaw, Poland
  • Cristina Popescu, MD, PhD, Carol Davila University of Medicine and Pharmacy, Romania
Support
Contributor
Meeting Partners
Endorsers
Language